The forest map showed that IGF2BP2, IGF2BP1, and HNRNPC were associated with poor prognosis in HNSCC patients, while their m6A regulators were not significantly associated with poor prognosis in HNSCC patients (Figure 1D). Here, IGF2BP1 is linked to head and neck squamous cell carcinoma.